Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANGIODYNAMICS INC Director's Dealing 2012

Aug 21, 2012

32939_dirs_2012-08-21_fb020053-8759-4401-992e-7d52a811f313.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2012-08-17

Reporting Person: DEVIVO JOSEPH (Director, President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-08-17 Common Stock A 22247 Acquired 63097 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-08-17 Non-Qualified Stock Option (right to buy) $10.63 A 35000 Acquired 2019-08-03 Common Stock (35000) Direct

Footnotes

F1: The acquisition of 22,247 shares of common stock represents 22,247 restricted stock units, each of which represents a contingent right to receive one share of AngioDynamics, Inc. common stock. The restricted stock units vest in four equal installments beginning on 8/3/2013.

F2: Options for 25% of the shares are each exercisable on 8/3/2013, 8/3/2014, 8/3/2015 and 8/3/2016, respectively.